Deutsch English Français

Contact

EP3613428

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3613428

EP3613428 - CYCLIC ACETYLCHOLINESTERASE C-TERMINAL PEPTIDE IN THE TREATMENT OR PREVENTION OF CANCER OR METASTASIS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 22.01.2021 Database last updated on 20.09.2024
Former	The application has been published Status updated on 24.01.2020
Most recent event Tooltip	22.01.2021	Application deemed to be withdrawn	published on 24.02.2021 [2021/08]
Applicant(s)	For all designated states Neuro-Bio Ltd Building F5 Culham Science Centre Abingdon, Oxfordshire OX14 3DB / GB
	[2020/09]
Inventor(s)	01 / GREENFIELD, Susan Building F5 Culham Science Centre Abingdon, Oxfordshire OX14 3BD / GB
	02 / PEPPER, Christopher c/o Institute of Cancer & Genetics Cardiff University School of Medicine Cancer Genetics Building Cardiff, South Glamorgan CF14 4XN / GB
	[2020/09]
Representative(s)	Hutter, Anton Venner Shipley LLP 5 Stirling House Stirling Road The Surrey Research Park Guildford GU2 7RF / GB
	[2020/09]
Application number, filing date	19172010.1	18.12.2015
	[2020/09]
Priority number, date	GB20140022715	19.12.2014 Original published format: GB 201422715
	GB20150008480	18.05.2015 Original published format: GB 201508480
	[2020/09]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP3613428
	Date:	26.02.2020
	Language:	EN
	[2020/09]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	24.01.2020
Classification	IPC:	A61K38/46, A61K38/12, A61P35/02, A61P35/04, C12N9/18	[2020/09]
	CPC:	A61K38/465 (EP,CN,GB,KR,RU,US); A61K38/12 (EP,CN,GB,KR,RU,US); A61P35/02 (EP,US); A61P35/04 (EP,US); C12N9/18 (EP,US); C12Y301/01007 (EP,CN,GB,KR,RU,US); (+) A61K38/00 (US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/09]
Title	German:	ZYKLICHES ACETYLCHOLINESTERASE C-TERMINALPEPTID ZUR BEHANDLUNG VON KREBS UND METASTASE	[2020/09]
	English:	CYCLIC ACETYLCHOLINESTERASE C-TERMINAL PEPTIDE IN THE TREATMENT OR PREVENTION OF CANCER OR METASTASIS	[2020/09]
	French:	PEPTIDE CYCLIQUE C-TERMINAL DE L'ACETYLCHOLINESTERASE POUR TRAITER LE CANCER ET LES METASTASES	[2020/09]
Examination procedure	27.08.2020	Application deemed to be withdrawn, date of legal effect [2021/08]
	23.09.2020	Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2021/08]
Parent application(s) Tooltip	EP15816833.6 / EP3233110
Fees paid	Renewal fee
	30.04.2019	Renewal fee patent year 03
	30.04.2019	Renewal fee patent year 04
	31.12.2019	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]WO9735962 (ISIS INNOVATION [GB], et al) [A] 1-15 * the whole document *;
		[XY]WO9802452 (UNIV MCGILL [CA]) [X] 1-3,5,11,14 * claims 11, 27, 45, 46 * [Y] 1-5,11,14,15;
		[X]WO0073427 (YISSUM RES DEV CO [IL], et al) [X] 14,15 * SEQ ID NO 2; pages 20,22, paragraph last; claims 14, 19, 20, 27 *;
		[XY]US2004204348 (JONES TERENCE R [US], et al) [X] 1-3,5,11,14 * claims 1,22,34,40 * [Y] 1-5,11,14,15;
		[Y]WO2007049281 (YISSUM RES DEV CO [IL], et al) [Y] 1-15 * SEQ ID NO: 5; page 38, lines 7-21; claims 15, 36, 49, 51 *;
		[Y]US2009169520 (SOREQ HERMONA [IL], et al) [Y] 1-15 * SEQ ID NO: 1;; figure 5e; claims 11, 15, 20 *;
		[Y]EP2754451 (SHANGHAI INST BIOL SCIENCES [CN]) [Y] 1-5,14 * claims 9, 15 *;
		[XP]WO2015004430 (NEURO BIO LTD [GB]) [XP] 14,15* example 16; claim - *;
		[Y] - ONGANER P U ET AL, "An acetylcholinesterase-derived peptide inhibits endocytic membrane activity in a human metastatic breast cancer cell line", BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - GENERAL SUBJECTS, ELSEVIER, AMSTERDAM, NL, vol. 1760, no. 3, doi:10.1016/J.BBAGEN.2005.12.016, ISSN 0304-4165, (20060301), pages 415 - 420, (20060301), XP025014834 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/j.bbagen.2005.12.016
	by applicant	- THOMPSON et al., Nucleic Acids Research, (19940000), vol. 22, pages 4673 - 4680
		- THOMPSON et al., Nucleic Acids Research, (19970000), vol. 24, pages 4876 - 4882
		- CHRISTOPHER J. WHITEANDREI K. YUDIN, Nature Chemistry, (20110000), vol. 3
		- VALERO et al., JPeptide Res., (19990000), vol. 53, pages 76 - 67
		- LIHU YANGGREG MORRIELLO, Tetrahedron Letters, (19990000), vol. 40, pages 8197 - 8200
		- PARVESH WADHWANI et al., J. Org. Chem., (20060000), vol. 71, pages 55 - 61

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p